200,000+ products from a single source!

sales@angenechem.com

Home > Thiazole > 261-86-9

261-86-9

261-86-9 | 1H-Phenothiazine

CAS No: 261-86-9 Catalog No: AG002RON MDL No:

Product Description

Catalog Number:
AG002RON
Chemical Name:
1H-Phenothiazine
CAS Number:
261-86-9
Molecular Formula:
C12H9NS
Molecular Weight:
199.2716
IUPAC Name:
1H-phenothiazine
InChI:
InChI=1S/C12H9NS/c1-3-7-11-9(5-1)13-10-6-2-4-8-12(10)14-11/h1-5,7-8H,6H2
InChI Key:
QWXDTDWOYQPERX-UHFFFAOYSA-N
SMILES:
C1=CC=C2C(=Nc3c(S2)cccc3)C1

Properties

Complexity:
327  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
199.046g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
199.271g/mol
Monoisotopic Mass:
199.046g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
37.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3  

Literature

Title Journal
Susceptibilities of the dermatophytes Trichophyton mentagrophytes and T. rubrum microconidia to photodynamic antimicrobial chemotherapy with novel phenothiazinium photosensitizers and red light. Journal of photochemistry and photobiology. B, Biology 20121105
Pluronic-Nanogold hybrids: synthesis and tagging with photosensitizing molecules. Colloids and surfaces. B, Biointerfaces 20120901
Phototoxicity of phenothiazinium dyes against methicillin-resistant Staphylococcus aureus and multi-drug resistant Escherichia coli. Photodiagnosis and photodynamic therapy 20120301
Comparative photodynamic evaluation of new phenothiazinium derivatives against Propionibacterium acnes. Photochemistry and photobiology 20120101
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Frontiers in microbiology 20120101
Micelle mediated trace level sulfide quantification through cloud point extraction. TheScientificWorldJournal 20120101
Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats. Journal of clinical periodontology 20111201
Photodynamic therapy for infections: clinical applications. Lasers in surgery and medicine 20110901
Photodynamic inactivation of drug-resistant bacteria isolated from diabetic foot ulcers. Iranian journal of microbiology 20110301
Drug discovery of antimicrobial photosensitizers using animal models. Current pharmaceutical design 20110101
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PloS one 20110101
Isolation and characterization of novel bacterial strains exhibiting ligninolytic potential. BMC biotechnology 20110101
Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy. Journal of medicinal chemistry 20101111
Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers in surgery and medicine 20100701
Biophysical studies on the base specificity and energetics of the DNA interaction of photoactive dye thionine: spectroscopic and calorimetric approach. Biophysical chemistry 20100501
Radiographic assessment of photodynamic therapy as an adjunctive treatment on induced periodontitis in immunosuppressed rats. Journal of applied oral science : revista FOB 20100101
Efflux pump inhibitor potentiates antimicrobial photodynamic inactivation of Enterococcus faecalis biofilm. Photochemistry and photobiology 20100101
Identifying experimental surrogates for Bacillus anthracis spores: a review. Investigative genetics 20100101
Methylene blue: revisited. Journal of anaesthesiology, clinical pharmacology 20100101
Molecular recognition of cationic phenothiazinium and phenoxazinium dyes with pi-extended 2'-deoxyadenosine nucleotides. Chemical communications (Cambridge, England) 20091128
Characterization of pHEMA-based hydrogels that exhibit light-induced bactericidal effect via release of NO. Journal of materials science. Materials in medicine 20091101
Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. Marine drugs 20090901
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090601
Treatment of experimental periodontal disease by photodynamic therapy in immunosuppressed rats. Journal of clinical periodontology 20090301
In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC microbiology 20090101
Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent. BMC microbiology 20090101
Synthesis and DNA interactions of a bis-phenothiazinium photosensitizer. Organic & biomolecular chemistry 20081107
Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes. Journal of periodontology 20081101
Photodynamic therapy: the development of new photosensitisers. Anti-cancer agents in medicinal chemistry 20080401
Antifungal photodynamic therapy. Microbiological research 20080101
Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20071001
Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20071001
Phenothiazinium derivatives for pathogen inactivation in blood products. Journal of photochemistry and photobiology. B, Biology 20070103
Phenothiazinium-based photobactericidal materials. Journal of photochemistry and photobiology. B, Biology 20060901
New photodynamic therapy protocol to treat AIDS-related Kaposi's sarcoma. Photomedicine and laser surgery 20060801
Light activated compounds as antimicrobial agents - patently obvious? Recent patents on anti-infective drug discovery 20060601
Phenothiazinium based photosensitisers--photodynamic agents with a multiplicity of cellular targets and clinical applications. Current drug targets 20050801
The phenothiazinium chromophore and the evolution of antimalarial drugs. Tropical medicine & international health : TM & IH 20050601
A study on the bacterial photo-toxicity of phenothiazinium based photosensitisers. FEMS immunology and medical microbiology 20050301
A comparative analysis of phenothiazinium salts for the photosensitisation of murine fibrosarcoma (RIF-1) cells in vitro. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20040701
The binding properties of photosensitizer methylene blue to herring sperm DNA: a spectroscopic study. Journal of photochemistry and photobiology. B, Biology 20040527
The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus. FEMS immunology and medical microbiology 20031024
Fast back electron transfer prevents guanine damage by photoexcited thionine bound to DNA. Journal of the American Chemical Society 20030813
Comparative antistreptococcal activity of photobactericidal agents. Journal of chemotherapy (Florence, Italy) 20030801
Enhancing the efficacy of photodynamic cancer therapy by radicals from plant auxin (indole-3-acetic acid). Cancer research 20030215
The use of dyes in modern biomedicine. Biotechnic & histochemistry : official publication of the Biological Stain Commission 20030101
Phenothiaziniums as putative photobactericidal agents for red blood cell concentrates. Journal of chemotherapy (Florence, Italy) 20011001

Related Products

© 2019 Angene International Limited. All rights Reserved.